These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 19893337

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Residual effects of ecstasy (3,4-methylenedioxymethamphetamine) on low level visual processes.
    Murray E, Bruno R, Brown J.
    Hum Psychopharmacol; 2012 Mar; 27(2):226-34. PubMed ID: 22389087
    [Abstract] [Full Text] [Related]

  • 3. A long-term ecstasy-related change in visual perception.
    Brown J, Edwards M, McKone E, Ward J.
    Psychopharmacology (Berl); 2007 Aug; 193(3):437-46. PubMed ID: 17457578
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC.
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [Abstract] [Full Text] [Related]

  • 10. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
    Gouzoulis-Mayfrank E, Daumann J.
    J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alterations to global but not local motion processing in long-term ecstasy (MDMA) users.
    White C, Brown J, Edwards M.
    Psychopharmacology (Berl); 2014 Jul; 231(13):2611-22. PubMed ID: 24441968
    [Abstract] [Full Text] [Related]

  • 15. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
    Indlekofer F, Piechatzek M, Daamen M, Glasmacher C, Lieb R, Pfister H, Tucha O, Lange KW, Wittchen HU, Schütz CG.
    J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
    Soar K, Turner JJ, Parrott AC.
    J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
    [Abstract] [Full Text] [Related]

  • 18. Executive function in abstinent MDMA ('ecstasy') users.
    Zakzanis KK, Young DA.
    Med Sci Monit; 2001 May; 7(6):1292-8. PubMed ID: 11687745
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.
    Reneman L, Schilt T, de Win MM, Booij J, Schmand B, van den Brink W, Bakker O.
    J Psychopharmacol; 2006 May; 20(3):389-99. PubMed ID: 16574713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.